All > Massachusetts Investigators

Miriam Bredella, MD

Massachusetts General Hospital

Boston, Massachusetts - 02114

CLINICAL TRIALS 2
CONDITIONS4
INTERVENTIONS1
SINCE2005

Neuroendocrine Modulation of Metabolic Effects in Overweight Adolescents

May 2005 - June 2007

Study to Examine Insulin Resistance During Growth Hormone Treatment for Short Stature Due to Low Birthweight

July 2005 - December 2011

Obesity

Overweight

Insulin Resistance

Fetal Growth Retardation

Somatropin (Rdna)

Learn about TrialX Patient Recruitment services

Massimo Loda, MD

Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute

Suzanne Shusterman

Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Childrens Hospital Boston, Dana-Farber Cancer Institute. Children's Hospital Boston

Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Dana-Farber Cancer Institute Dana Farber / Brigham and Women's Cancer Center Dana-Farber Cancer Institute, Center for Neuro-Oncology Dana-Farber Cancer Instiute

Lewis B. Silverman, MD

Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Dana-Farber Cancer Institute and Children's Hospital Dana Faber Cancer Institute, Children's Hospital, Dept. of Pediatric Oncology Children's Hospital Boston Dana-Farber Cancer Institute

Miriam Bredella, MD

Massachusetts General Hospital

Massimo Loda, MD

Suzanne Shusterman

Patrick Y. Wen, MD

Lewis B. Silverman, MD

Kay Kehoe, Coordinator

Jennifer Brown, MD

Rachel A. Freedman

Edwin P. Alyea, MD

F. Stephen Hodi, MD

Beth A. Overmoyer, MD, FACP